Global Patient Safety Therapeutic Area Biopharma Intern

AstraZeneca is an innovation-driven global biopharmaceutical company focused on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, renal and metabolic, respiratory and immunological, oncological and rare diseases.
In line with our firm commitment to training and developing exceptional talent, this person will join our Global Patient Safety area to learn and grow through active collaboration with our team.
Conditions:
Duration: 1 year
Hours per day: Full time
Location: Barcelona
Focus area: Global Patient Safety Therapeutic Area Biopharma
Training through practical experience:
Do you have a passion for Patient Safety? Would you like to learn more and apply your knowledge expertise to support Global Patient Safety team in a company that follows the science and turns ideas into life changing medicines? Then AstraZeneca might be the one for you!
At AstraZeneca, we put patients first and we turn ideas into life changing medicines. Working here means being entrepreneurial, thinking big and working together to make the impossible a reality. If you are swift to action, willing to collaborate, and curious about what science can do, then you’re our kind of person.
Global Patient Safety TA BioPharma at AstraZeneca is now looking for an Intern to join our team in Barcelona.
The core purpose of Patient Safety is to add value to AstraZeneca products, provide clear science-based guidance for investigators and prescribers to safeguard patients as well as the success of our business. Patient Safety covers the entire clinical life cycle of a drug from first time into man to withdrawal of a product from the market.
You will participate by providing support in ongoing pharmacovigilance and patient safety activities and projects. These projects will be outlined at the beginning of the internship period and when opportunities arise during the year.
You will also collaborate on our weekly or monthly safety data review with the project safety team, including literature retrieval and evaluation and/or drug information questions.
You will also contribute to the organization by providing at least one presentation on a topic to be determined, and/ or a training session to our colleagues on a specific matter.
You will be involved in as many tasks and activities that will support you gaining pharmacovigilance and patient safety knowledge.
Requirements
Being a 3rd / 4th year undergraduate student or a 1st year post graduate student in an accredited university, preferably at Faculty of Health Sciences or Medicine.
Good command of written and spoken English
Self-starter who demonstrates energy and enthusiasm, bringing a positive can-do approach to all challenges
Having excellent presentation and communication skills
High degree of accuracy with attention to detail
Competent in MS Office applications (e.g. Word, Excel, PowerPoint)
High degree of analytical thinking skills and the ability to analyse data.
AstraZeneca is a company that promotes equal opportunities. AstraZeneca will consider all eligible persons, without discrimination based on disability, sex or sexual orientation, pregnancy or maternity/paternity period, race or origin (national or ethnic), age, religion or belief, identity of gender, marital or de facto partnership status and/or any other characteristic protected by law.
Date Posted 20-sept-2024
Closing Date 26-sept-2024
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.
AstraZeneca

Fecha de publicación: 22/09/2024